A study conducted on human airway smooth muscle cells showed that the use of astragaloside IV (ASIV) to treat asthma significantly affects HMGB1 by weakening the expression of this protein and thus preventing its entry into the cytoplasm. The gene discussed is HMGB1; the disease is asthma.